OLEMA PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
OLEMA PHARMACEUTICALS, INC. (OLMA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 39.33 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-11
- OLEMA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 39.33M shares, a 1416.43% increase year-over-year.
- OLEMA PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 2.59M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month |
|---|---|
| 2021-03-31 | 39.33M shares 10-Q · filed 2021-05-11 |
| 2020-03-31 | 2.59M shares 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |